CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- 4 Grant or award Director acquired 15,216 shares (grant or award)
- 4 Grant or award Director acquired 15,216 shares (grant or award)
- 4 Open-market sale GENERAL COUNSEL sold 5,475 shares at $6.97 ($38,161)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 4,297 shares at $6.97 ($29,950)
- 4 Grant or award Director acquired 15,216 shares (grant or award)
- 4 Grant or award Director acquired 15,216 shares (grant or award)
- 4 Grant or award Director acquired 15,216 shares (grant or award)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $8.71 ($10,313)
- 4 Grant or award Chief Financial Officer & PAO acquired 125,870 shares (grant or award)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $7.49 ($8,868)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $9.36 ($11,082)
- 4 Grant or award PRESIDENT AND CEO acquired 205,286 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4/A Grant or award CHIEF COMMERCIAL OFFICER acquired 69,100 shares (grant or award)
- 4/A Grant or award INTERIM CFO acquired 28,800 shares (grant or award)
- 4/A Grant or award GENERAL COUNSEL acquired 69,100 shares (grant or award)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 3,097 shares at $9.06 ($28,059)
- 4 Open-market sale INTERIM CFO sold 1,078 shares at $9.06 ($9,767)
- 4 Open-market sale GENERAL COUNSEL sold 4,351 shares at $9.06 ($39,420)
Page 4 of 12 · 229 filings